Cravath’s New York Office Moves to Two Manhattan West
Widely recognized as a leader in intellectual property litigation, Cravath has handled challenging intellectual property disputes for generations, often involving our clients’ most valuable and complex technologies and products. Today, our expertise covers the entire innovation marketplace, spanning the pharmaceutical, biotechnology, consumer products, technology and industrial sectors, among others. In a quickly advancing intellectual property landscape, Cravath’s litigators devise effective solutions to complex problems by combining “incredible intellectual horsepower, diligence, exceptional teamwork and dedication.” (IAM Patent 1000)
Clients ranging from innovative start-ups to major global companies regularly call on Cravath to lead intellectual property matters of the highest complexity and business significance. Our attorneys bring to the table not only “incredible IP and policy knowledge,” but also outside‑the‑box thinking, courtroom credibility and masterful trial advocacy in all aspects of high‑stakes intellectual property litigation. (Chambers USA) Cravath’s litigators are adept at handling a wide variety of disputes involving patents, copyrights, trade secrets and trademarks, as well as the commercial litigation that frequently arises from these matters, such as antitrust and breach of license claims. We bring to each case a trial lawyer’s courtroom perspective and deep trial experience, which distinguishes us from many firms that may be intellectual property specialists but do not try cases on a regular basis.
Our team also supervises and coordinates intellectual property disputes that span the globe and regularly advises on national and worldwide intellectual property strategy, earning praise for our “ability to orchestrate litigation pretty much anywhere in the world.” (Chambers USA)
Cravath has handled patent litigation since the nineteenth century, and we continue to be at the forefront of the field, tackling today’s most “brain‑bendingly complex must‑win company suits.” (IAM Patent 1000) We regularly work with cutting‑edge pharmaceutical, medical device and technology companies in highly contested patent litigation that goes to the heart of our clients’ businesses. Notably, we have significant experience taking patent cases to trial, particularly in the biotechnology area, and litigated one of the first cases to proceed under the Biologics Price Competition and Innovation Act.
Cravath has received first‑tier rankings in patent litigation in the Best Lawyers survey of the best law firms in the United States, has been recognized for patent litigation by LMG Life Sciences and Intellectual Asset Management, and was named among Patexia Insight’s Top Inter Partes Review Firms of 2022. The Legal 500 US has credited the Firm’s “superb trial lawyers with a long track record in dealing with complex patent litigation,” and noted that “when stakes are high in a patent case, Cravath is the team to engage.”
Cravath has extensive experience representing content owners, content distributors and others in prosecuting and defending copyright infringement claims, including in landmark actions that shape the law’s development. We have established important precedent impacting copyright-heavy industries like film, television, music and digital media, and recently won a U.S. Supreme Court decision holding that the Copyright Act permits damages recovery for any timely filed infringement claim, regardless of when the infringement occurred. A victory for all creators of copyrightable works, the ruling resolved a critical issue that had divided the federal appellate courts. In addition to our active litigation practice, we routinely advise clients on a variety of copyright issues, including related to the Digital Millennium Copyright Act, renewal rights issues, digital media and other new and emerging technologies. We also regularly advise on potential copyright and other contractual issues in programming, recording and publishing contracts.
The breadth and depth of Cravath’s litigation expertise is invaluable in prosecuting (or defending) claims involving trade secrets. The Legal 500 US noted Cravath’s particular strength “in bringing complex, high‑value trade secret disputes to trial on behalf of plaintiffs in the insurance, finance and technology sectors, and defending them against claims,” as well as the Firm’s “considerable track record advising various parties on strategies to avoid trade secrets disputes.” Cravath also possesses substantial experience in investigating potential or suspected misuse or misappropriation of trade secrets. The Firm frequently advises clients on methods of protecting proprietary information, including confidentiality and noncompetition agreements with employees, and conducts due diligence with respect to unpatented proprietary information in connection with mergers and acquisitions and other transactions.
Cravath advises and represents clients on a wide range of issues arising under the trademark laws. We have defended clients against allegations of trademark infringement and trademark dilution, as well as against related claims of unfair competition and breach of trademark licensing agreements. We also have brought claims and counterclaims to enforce important trademark rights.
Named New York Law Journal’s “Litigation Department of the Year” in 2024, 2022 and 2019 and a Law360 Firm of the Year in 2021, Cravath’s IP team has been ranked as a leading or top tier firm in the intellectual property space by Benchmark Litigation, Chambers USA, Chambers Global, IAM Patent 1000, LMG Life Sciences, The Legal 500 US and Best Lawyers Best Law Firms. In addition, we have earned repeated praise from clients and the market, including:
Clients ranging from innovative start-ups to major global companies regularly call on Cravath to lead intellectual property matters of the highest complexity and business significance. Our attorneys bring to the table not only “incredible IP and policy knowledge,” but also outside‑the‑box thinking, courtroom credibility and masterful trial advocacy in all aspects of high‑stakes intellectual property litigation. (Chambers USA) Cravath’s litigators are adept at handling a wide variety of disputes involving patents, copyrights, trade secrets and trademarks, as well as the commercial litigation that frequently arises from these matters, such as antitrust and breach of license claims. We bring to each case a trial lawyer’s courtroom perspective and deep trial experience, which distinguishes us from many firms that may be intellectual property specialists but do not try cases on a regular basis.
Our team also supervises and coordinates intellectual property disputes that span the globe and regularly advises on national and worldwide intellectual property strategy, earning praise for our “ability to orchestrate litigation pretty much anywhere in the world.” (Chambers USA)
Cravath has handled patent litigation since the nineteenth century, and we continue to be at the forefront of the field, tackling today’s most “brain‑bendingly complex must‑win company suits.” (IAM Patent 1000) We regularly work with cutting‑edge pharmaceutical, medical device and technology companies in highly contested patent litigation that goes to the heart of our clients’ businesses. Notably, we have significant experience taking patent cases to trial, particularly in the biotechnology area, and litigated one of the first cases to proceed under the Biologics Price Competition and Innovation Act.
Cravath has received first‑tier rankings in patent litigation in the Best Lawyers survey of the best law firms in the United States, has been recognized for patent litigation by LMG Life Sciences and Intellectual Asset Management, and was named among Patexia Insight’s Top Inter Partes Review Firms of 2022. The Legal 500 US has credited the Firm’s “superb trial lawyers with a long track record in dealing with complex patent litigation,” and noted that “when stakes are high in a patent case, Cravath is the team to engage.”
Cravath has extensive experience representing content owners, content distributors and others in prosecuting and defending copyright infringement claims, including in landmark actions that shape the law’s development. We have established important precedent impacting copyright-heavy industries like film, television, music and digital media, and recently won a U.S. Supreme Court decision holding that the Copyright Act permits damages recovery for any timely filed infringement claim, regardless of when the infringement occurred. A victory for all creators of copyrightable works, the ruling resolved a critical issue that had divided the federal appellate courts. In addition to our active litigation practice, we routinely advise clients on a variety of copyright issues, including related to the Digital Millennium Copyright Act, renewal rights issues, digital media and other new and emerging technologies. We also regularly advise on potential copyright and other contractual issues in programming, recording and publishing contracts.
The breadth and depth of Cravath’s litigation expertise is invaluable in prosecuting (or defending) claims involving trade secrets. The Legal 500 US noted Cravath’s particular strength “in bringing complex, high‑value trade secret disputes to trial on behalf of plaintiffs in the insurance, finance and technology sectors, and defending them against claims,” as well as the Firm’s “considerable track record advising various parties on strategies to avoid trade secrets disputes.” Cravath also possesses substantial experience in investigating potential or suspected misuse or misappropriation of trade secrets. The Firm frequently advises clients on methods of protecting proprietary information, including confidentiality and noncompetition agreements with employees, and conducts due diligence with respect to unpatented proprietary information in connection with mergers and acquisitions and other transactions.
Cravath advises and represents clients on a wide range of issues arising under the trademark laws. We have defended clients against allegations of trademark infringement and trademark dilution, as well as against related claims of unfair competition and breach of trademark licensing agreements. We also have brought claims and counterclaims to enforce important trademark rights.
Named New York Law Journal’s “Litigation Department of the Year” in 2024, 2022 and 2019 and a Law360 Firm of the Year in 2021, Cravath’s IP team has been ranked as a leading or top tier firm in the intellectual property space by Benchmark Litigation, Chambers USA, Chambers Global, IAM Patent 1000, LMG Life Sciences, The Legal 500 US and Best Lawyers Best Law Firms. In addition, we have earned repeated praise from clients and the market, including:
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Deals & Cases
May 11, 2024
On May 9, 2024, the U.S. Supreme Court ruled in favor of Cravath client Sherman Nealy, affirming the U.S. Court of Appeals for the Eleventh Circuit’s ruling that the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred. The Supreme Court’s decision resolves a split between the Ninth and Eleventh Circuits and the Second Circuit and holds that Nealy may seek damages for copyright infringement claims against Warner Chappell Music.
Deals & Cases
January 29, 2024
On January 25, 2024, the U.S. District Court for the Southern District of New York entered judgments against appropriation artist Richard Prince and his co‑defendants Laurence Gagosian, Gagosian Gallery and Blum & Poe gallery.
Deals & Cases
October 09, 2023
On September 22, 2023, the U.S. District Court for the District of Massachusetts ruled in favor of Cravath clients Abiomed, Inc. and Abiomed Europe GmbH (together, “Abiomed”), denying a motion to dismiss litigation brought by Abiomed against German defendants Enmodes GmbH and its CEO Tim Kaufmann.
Deals & Cases
May 19, 2023
On May 11, 2023, the U.S. District Court for the Southern District of New York denied summary judgment to appropriation artist Richard Prince and his associated galleries in two copyright infringement cases brought by Cravath clients, the photographers Donald Graham and Eric McNatt, regarding works from Prince’s “New Portraits” series.
Activities & Publications
September 30, 2024
On September 30, 2024, Cravath partner Sharonmoyee Goswami participated in “Patent Law Institute 2024: Critical Issues & Best Practices New York,” a program presented by the Practising Law Institute in New York. Sharon delivered a presentation entitled “Patent Law – A Year in Review,” which reviewed recent Supreme Court certiorari grants, major Federal Circuit opinions and en banc petitions, changes in USPTO proceedings and the shifting landscape in design patents.
Accolades
September 06, 2024
On September 6, 2024, Lawdragon announced the inclusion of 37 Cravath partners in its list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “the best litigators the U.S. has to offer” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Accolades
July 17, 2024
On June 6, 2024, Cravath partner David R. Marriott was recognized by Leaders League as a leading trial lawyer in the United States. The profile praised Dave’s “uncommon ability to consistently win complex cases of every hue, often against all odds,” as exemplified by his representation of clients including Illumina in its unprecedented antitrust trial victory against the FTC; Amgen in its successful defense against the FTC’s challenge to its $27.8 billion acquisition of Horizon Therapeutics; Louis Dreyfus Company and Imperial Sugar Company in their trial victory over the DOJ; Viatris in its summary judgment win to defeat a securities class action; and photographers Donald Graham and Eric McNatt, who secured favorable SDNY judgments in copyright infringement litigation against appropriation artist Richard Prince and his galleries. The publication deemed his work on the antitrust cases “a string of stunning…victories” in “three of the most significant antitrust cases of the last decade.” Leaders League further remarked that “Marriott never shirks from a challenge, no matter how daunting [the] odds or opposition.”
Activities & Publications
July 11, 2024
On July 9, 2024, the Committee on Patents of the New York City Bar Association (“Patents Committee”) submitted comments on the proposed amendment from the U.S. Patent and Trademark Office (“USPTO”) to its terminal disclaimer rules, co‑authored by Cravath partner and Patents Committee Chair Sharonmoyee Goswami. The comments discuss the potential implications of the proposed amendment, which would require patent applicants to agree that a patent subject to a terminal disclaimer would be unenforceable if any claim of a patent tied by the terminal disclaimer is found invalid as anticipated or obvious.
Accolades
June 27, 2024
On June 25, 2024, Cravath was honored for the second consecutive year with the Gold Award as “Best US Law Firm” at the 2024 Leaders League Alliance Summit: Law & Innovation, which was held in Miami. The award was accepted by partner David R. Marriott on the Firm’s behalf. Winners were selected by more than 80 jury members “through an extremely rigorous judging process” based on nominees’ “experience and market knowledge.” The information on which Cravath’s selection was based included its representation of global companies on large and complex M&A transactions, antitrust litigation and investigations matters, as well as its innovative use of new legal technology tools.
Deals & Cases
October 17, 2024
On October 15, 2024, the United States Court of Appeals for the Federal Circuit affirmed an inter partes review (“IPR”) decision by the Patent Trial and Appeal Board (“PTAB”) in favor of Cravath client ADT Inc., invalidating all claims of a patent at issue in litigation brought by Vivint, Inc.
Deals & Cases
May 11, 2024
On May 9, 2024, the U.S. Supreme Court ruled in favor of Cravath client Sherman Nealy, affirming the U.S. Court of Appeals for the Eleventh Circuit’s ruling that the Copyright Act entitles a copyright owner to obtain damages for any timely filed infringement claim, regardless of when the infringement occurred. The Supreme Court’s decision resolves a split between the Ninth and Eleventh Circuits and the Second Circuit and holds that Nealy may seek damages for copyright infringement claims against Warner Chappell Music.
Deals & Cases
January 29, 2024
On January 25, 2024, the U.S. District Court for the Southern District of New York entered judgments against appropriation artist Richard Prince and his co‑defendants Laurence Gagosian, Gagosian Gallery and Blum & Poe gallery.
Deals & Cases
October 09, 2023
On September 22, 2023, the U.S. District Court for the District of Massachusetts ruled in favor of Cravath clients Abiomed, Inc. and Abiomed Europe GmbH (together, “Abiomed”), denying a motion to dismiss litigation brought by Abiomed against German defendants Enmodes GmbH and its CEO Tim Kaufmann.
Deals & Cases
May 19, 2023
On May 11, 2023, the U.S. District Court for the Southern District of New York denied summary judgment to appropriation artist Richard Prince and his associated galleries in two copyright infringement cases brought by Cravath clients, the photographers Donald Graham and Eric McNatt, regarding works from Prince’s “New Portraits” series.
Activities & Publications
September 30, 2024
On September 30, 2024, Cravath partner Sharonmoyee Goswami participated in “Patent Law Institute 2024: Critical Issues & Best Practices New York,” a program presented by the Practising Law Institute in New York. Sharon delivered a presentation entitled “Patent Law – A Year in Review,” which reviewed recent Supreme Court certiorari grants, major Federal Circuit opinions and en banc petitions, changes in USPTO proceedings and the shifting landscape in design patents.
Accolades
September 06, 2024
On September 6, 2024, Lawdragon announced the inclusion of 37 Cravath partners in its list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “the best litigators the U.S. has to offer” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Accolades
July 17, 2024
On June 6, 2024, Cravath partner David R. Marriott was recognized by Leaders League as a leading trial lawyer in the United States. The profile praised Dave’s “uncommon ability to consistently win complex cases of every hue, often against all odds,” as exemplified by his representation of clients including Illumina in its unprecedented antitrust trial victory against the FTC; Amgen in its successful defense against the FTC’s challenge to its $27.8 billion acquisition of Horizon Therapeutics; Louis Dreyfus Company and Imperial Sugar Company in their trial victory over the DOJ; Viatris in its summary judgment win to defeat a securities class action; and photographers Donald Graham and Eric McNatt, who secured favorable SDNY judgments in copyright infringement litigation against appropriation artist Richard Prince and his galleries. The publication deemed his work on the antitrust cases “a string of stunning…victories” in “three of the most significant antitrust cases of the last decade.” Leaders League further remarked that “Marriott never shirks from a challenge, no matter how daunting [the] odds or opposition.”
Activities & Publications
July 11, 2024
On July 9, 2024, the Committee on Patents of the New York City Bar Association (“Patents Committee”) submitted comments on the proposed amendment from the U.S. Patent and Trademark Office (“USPTO”) to its terminal disclaimer rules, co‑authored by Cravath partner and Patents Committee Chair Sharonmoyee Goswami. The comments discuss the potential implications of the proposed amendment, which would require patent applicants to agree that a patent subject to a terminal disclaimer would be unenforceable if any claim of a patent tied by the terminal disclaimer is found invalid as anticipated or obvious.
Accolades
June 27, 2024
On June 25, 2024, Cravath was honored for the second consecutive year with the Gold Award as “Best US Law Firm” at the 2024 Leaders League Alliance Summit: Law & Innovation, which was held in Miami. The award was accepted by partner David R. Marriott on the Firm’s behalf. Winners were selected by more than 80 jury members “through an extremely rigorous judging process” based on nominees’ “experience and market knowledge.” The information on which Cravath’s selection was based included its representation of global companies on large and complex M&A transactions, antitrust litigation and investigations matters, as well as its innovative use of new legal technology tools.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.